Sort   by:  
 Page size 
TranscriptomicsPhase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma
An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the setting of isolated limb infusion Gene expression profiles were obtained from 28 lesions across 15 patients and evaluated for expression values that correlated wit...
ORGANISM(S): Homo sapiens 
2011-01-01 | E-GEOD-22968 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of rat animal model of extremity melanoma after treatment with ADH-1 in combination with melphalan
To identify patterns of change in gene expression that correlated with drug treatment (saline control, ADH-1 alone, melphalan alone and ADH-1 plus melphalan) in our animal model of regional therapy for extremity melanoma we evaluated gene expression using microarray genechips and a Pearson correlati...
ORGANISM(S): Homo sapiens 
2008-11-07 | E-GEOD-8615 | biostudies-arrayexpress
GenomicsRhodococcus sp. ADH
Rhodococcus sp. ADH Genome sequencing and assembly
PRJNA294916 | ENA
GenomicsLactobacillus paragasseri strain:ADH
Lactobacillus paragasseri strain:ADH Genome sequencing and assembly
PRJNA217792 | ENA
TranscriptomicsSPROUTY2 target genes in human colon carcinoma cells
The role of SPROUTY2 (SPRY2) in human colon cancer is controversial. Our data support a tumorigenic action of SPRY2. We use microarrays to identify SPRY2 target genes in human SW480 ADH colon carcinoma cell line. RNA was obtained from SW480 ADH cells, Mock transfected or transfected with WT or two d...
ORGANISM(S): Homo sapiens 
2016-08-01 | E-GEOD-56941 | biostudies-arrayexpress
TranscriptomicsEarly Dysregulation of Cell Adhesion and Extracellular Matrix Pathways in Breast Cancer Progression
Proliferative breast lesions, such as simple ductal hyperplasia (SH) and atypical ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in situ (DCIS) and invasive cancer. To better understand their relationship to more advanced disease, we used microdissection and DNA microarrays t...
ORGANISM(S): Homo sapiens 
2009-09-08 | E-GEOD-16873 | biostudies-arrayexpress
GenomicsGene expression changes in tumor following ADH-503 treatment
Gene expression changes in tumor following ADH-503 treatment
PRJNA524652 | ENA
GenomicsAegiceras corniculatum
Aegiceras corniculatum ADH
PRJNA799767 | ENA
TranscriptomicsIn vivo study of ADH-1 in combination with melphalan for treatment of melanoma
To identify patterns of change in gene expression that correlated with drug treatment (saline control, ADH-1 alone, melphalan alone and ADH-1 plus melphalan) in our animal model of regional therapy for extremity melanoma we evaluated gene expression using microarray genechips and a Pearson correlati...
ORGANISM(S): Homo sapiens 
2008-10-30 | GSE8615 | GEO
TranscriptomicsGene expression changes in tumor following ADH-503 treatment
To understand the effect of ADH-503, we have employed microarray expression profiling to identify genes that change at different times 48hrs and 10 days after treatment initiation. CD11b/18 (alphaMbeta2), an integrin molecule is highly expressed on all myeloid cells and plays an important role in tr...
ORGANISM(S): Mus musculus 
2019-02-28 | GSE127258 | GEO
Sort   by:  
 Page size